Dataset | Â | Gene selection method | |||||||
---|---|---|---|---|---|---|---|---|---|
MaPSOGS | Geometric PSO | PSO | RMA | RPSW | EPSO | Hybrid BPSO-BBHA | PSOC4.5 | ||
AMLGSE2191 | Acc (%) | 100 (1) | 89.01 (7) | 82.29 (8) | 96.29 (3) | 90.48 (6) | 91.63 (5) | 94.26 (4) | 96.88 (2) |
 | Std | 1.58 | 2.68 | 3.54 | 1.80 | 2.11 | 2.37 | 3.01 | 2.93 |
Colon | Acc (%) | 99.52 (2) | 89.93 (7) | 86.63 (8) | 100 (1) | 91.38 (5) | 91.01 (6) | 92.25 (4) | 95.27 (3) |
 | Std | 1.90 | 2.25 | 3.18 | 2.81 | 3.18 | 3.20 | 1.31 | 6.38 |
DLBCL | Acc (%) | 98.84 (1) | 86.08 (7) | 83.54 (8) | 95.15 (2) | 94.24 (3) | 91.75 (6) | 92.06 (5) | 92.65 (4) |
 | Std | 1.36 | 0.63 | 0.81 | 0.88 | 2.32 | 1.20 | 0.77 | 1.65 |
Leukaemia | Acc (%) | 98.71 (1) | 86.13 (7) | 82.39 (8) | 96.81 (2) | 91.90 (4) | 90.96 (5) | 89.92 (6) | 93.46 (3) |
 | Std | 1.90 | 1.44 | 1.85 | 1.44 | 1.71 | 1.58 | 0.76 | 1.39 |
Prostate | Acc (%) | 98.38 (1) | 85.96 (7) | 84.55 (8) | 97.41 (2) | 90.51 (4) | 89.14 (5) | 87.92 (6) | 91.81 (3) |
 | Std | 0.33 | 2.10 | 1.60 | 1.29 | 1.21 | 1.60 | 2.76 | 4.51 |
MLL | Acc (%) | 96.38 (1) | 81.26 (8) | 81.67 (7) | 91.23 (3) | 86.53 (5) | 85.98 (6) | 86.75 (4) | 91.63 (2) |
 | Std | 1.51 | 3.46 | 4.26 | 3.63 | 3.40 | 3.64 | 4.65 | 3.32 |
SRBCT | Acc (%) | 98.91 (1) | 84.56 (7) | 83.28 (8) | 95.37 (2) | 91.50 (5) | 90.11 (6) | 91.70 (4) | 93.03 (3) |
 | Std | 2.42 | 4.44 | 2.50 | 4.87 | 4.80 | 1.49 | 3.63 | 2.98 |
Average | Acc (%) | 98.68 (1.14) | 86.13 (7.14) | 83.48 (7.85) | 96.04 (2.14) | 90.93 (4.57) | 90.08 (5.57) | 90.69 (4.71) | 93.53 (2.85) |
 | Std | 1.57 | 2.43 | 2.53 | 2.39 | 2.67 | 2.15 | 2.41 | 3.31 |